Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment. (Record no. 29483464)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01947 a2200565 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518030613.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202009s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1179-1926 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/s40262-019-00754-4 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Rolfo, Christian |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20200902 |
| 245 00 - TITLE STATEMENT | |
| Title | Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Clinical pharmacokinetics |
| Date of publication, distribution, etc. | 09 2019 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1165-1174 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Administration, Oral |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Kidney |
| General subdivision | physiopathology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Metabolic Clearance Rate |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasms |
| General subdivision | complications |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | No-Observed-Adverse-Effect Level |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Phthalazines |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Piperazines |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Poly(ADP-ribose) Polymerase Inhibitors |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Renal Insufficiency |
| General subdivision | etiology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Safety |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | de Vos-Geelen, Judith |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Isambert, Nicolas |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Molife, L Rhoda |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schellens, Jan H M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | De Grève, Jacques |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dirix, Luc |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Grundtvig-Sørensen, Peter |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jerusalem, Guy |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Leunen, Karin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mau-Sørensen, Morten |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Plummer, Ruth |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Learoyd, Maria |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bannister, Wendy |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fielding, Anitra |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ravaud, Alain |
| 773 0# - HOST ITEM ENTRY | |
| Title | Clinical pharmacokinetics |
| Related parts | vol. 58 |
| -- | no. 9 |
| -- | p. 1165-1174 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1007/s40262-019-00754-4">https://doi.org/10.1007/s40262-019-00754-4</a> |
| Public note | Available from publisher's website |
No items available.